Ophthalmic composition for improving complex eye symptoms

The ophthalmic composition combining vitamin A and a fat-soluble antioxidant with additional agents effectively addresses a range of eye symptoms, including fatigue and blurred vision, offering improved relief and prevention.

JP7612479B2Active Publication Date: 2025-01-14ROHTO PHARM CO LTD
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
JP2021053779
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-03-26
Publication Date
2025-01-14
Estimated Expiration
2036-07-29

Smart Images

  • Figure 0007612479000001
    Figure 0007612479000001
  • Figure 0007612479000002
    Figure 0007612479000002
  • Figure 0007612479000003
    Figure 0007612479000003
Patent Text Reader

Abstract

To provide an ophthalmic composition that can improve eye symptoms.SOLUTION: An ophthalmic composition for improving composite eye symptoms contains (A) at least one selected from the group of vitamin A of 40,000-200,000 IU / 100 mL, and (B) a lipid-soluble antioxidant.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Use of ophthalmic compositions containing vitamin a and vitamin e

    JP2002527391A

  • Eye drop composition

    JP2004059479A

  • Method of stabilizing ophthalmic composition and vitamin a family

    JP2009173638A

  • Ophthalmic composition for contact lens

    JP2011246418A

  • Ophthalmic composition

    JP2013181020A